Literature DB >> 25267983

Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology.

Gary M Franklin1.   

Abstract

The Patient Safety Subcommittee requested a review of the science and policy issues regarding the rapidly emerging public health epidemic of prescription opioid-related morbidity and mortality in the United States. Over 100,000 persons have died, directly or indirectly, from prescribed opioids in the United States since policies changed in the late 1990s. In the highest-risk group (age 35-54 years), these deaths have exceeded mortality from both firearms and motor vehicle accidents. Whereas there is evidence for significant short-term pain relief, there is no substantial evidence for maintenance of pain relief or improved function over long periods of time without incurring serious risk of overdose, dependence, or addiction. The objectives of the article are to review the following: (1) the key initiating causes of the epidemic; (2) the evidence for safety and effectiveness of opioids for chronic pain; (3) federal and state policy responses; and (4) recommendations for neurologists in practice to increase use of best practices/universal precautions most likely to improve effective and safe use of opioids and to reduce the likelihood of severe adverse and overdose events.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25267983     DOI: 10.1212/WNL.0000000000000839

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  77 in total

1.  Capsule Commentary on Gaither et al., The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.

Authors:  Gary M Franklin
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

2.  Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center.

Authors:  Mia T Minen; Kate Lindberg; Rebecca E Wells; Joji Suzuki; Corita Grudzen; Laura Balcer; Elizabeth Loder
Journal:  Headache       Date:  2015-08-28       Impact factor: 5.887

Review 3.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.

Authors:  Charl Els; Tanya D Jackson; Diane Kunyk; Vernon G Lappi; Barend Sonnenberg; Reidar Hagtvedt; Sangita Sharma; Fariba Kolahdooz; Sebastian Straube
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

Review 4.  Therapeutic Utility of Opioids for Restless Legs Syndrome.

Authors:  Susan E Mackie; John W Winkelman
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

5.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

6.  Clinical Interventional Oncology Symposium And Integrative Healthcare Symposium.

Authors:  Walter Alexander
Journal:  P T       Date:  2017-04

Review 7.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

8.  Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.

Authors:  Jeffrey F Scherrer; Joanne Salas; Laurel A Copeland; Eileen M Stock; Brian K Ahmedani; Mark D Sullivan; Thomas Burroughs; F David Schneider; Kathleen K Bucholz; Patrick J Lustman
Journal:  Ann Fam Med       Date:  2016 Jan-Feb       Impact factor: 5.166

9.  Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Daniel J Urban; Xiaohui Wang; Michael V Baratta; Timothy J Fabisiak; Nathan D Anderson; Kejun Cheng; Lisa I Greene; Debra Berkelhammer; Yingning Zhang; Amanda L Ellis; Hang Hubert Yin; Serge Campeau; Kenner C Rice; Bryan L Roth; Steven F Maier; Linda R Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 10.  Update of HIV-Associated Sensory Neuropathies.

Authors:  Angela Aziz-Donnelly; Taylor B Harrison
Journal:  Curr Treat Options Neurol       Date:  2017-08-31       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.